C-Met/HDAC-IN-2
C-Met/HDAC-IN-2 is a highly potent c-Met and HDAC dual inhibitor with IC50s of 18.49 nM and 5.40 nM for HDAC1 and c-Met, respectively. c-Met/HDAC-IN-2 has antiproliferative activities against certain cancer cell lines. c-Met/HDAC-IN-2 can cause G2/M-phase arrest and induce apoptosis in HCT-116. c-Met/HDAC-IN-2 can be used for researching anti-cancer resistance[1].
Product Specifications
CAS Number
[2740495-53-6]
UNSPSC
12352005
Target
Apoptosis; c-Met/HGFR; HDAC
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/c-met-hdac-in-2.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=NN(C2=CC=CC=C2)C=CC1=O)NC3=CC=C(OC4=CC=NC5=CC(OCCCCCCC(NO)=O)=C(OC)C=C45)C=C3
Molecular Formula
C34H33N5O7
Molecular Weight
623.66
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ABIN-1 (A-20 Binding Inhibitor of Nuclear Factor-kappaB (NF-kB) Activation, HIV-1 Nef-interacting Protein, KIAA0113, Nef-associated Factor 1, Naf1, Nip40-1, TNFAIP3 Interacting Protein 1, TNIP1, Virion-associated Nuclear Shuttling Protein, VAN, hVAN)
GIF (Gastric Intrinsic Factor, Intrinsic Factor, IF, INF, IFMH) (PE)
Cytokeratin 6 (CK6A, CK6B, CK6C, CK6D, CK6E, Keratin Type II Cytoskeletal 6A, Keratin Type II Cytoskeletal 6B, Keratin Type II Cytoskeletal 6C, Keratin Type II Cytoskeletal 6D, Keratin Type II Cytoskeletal 6E, KRT6, KRT6A, KRT6B, KRT6C, KRT6D, KRT6E) (BSA
Cytokeratin 6 (CK6A, CK6B, CK6C, CK6D, CK6E, Keratin Type II Cytoskeletal 6A, Keratin Type II Cytoskeletal 6B, Keratin Type II Cytoskeletal 6C, Keratin Type II Cytoskeletal 6D, Keratin Type II Cytoskeletal 6E, KRT6, KRT6A, KRT6B, KRT6C, KRT6D, KRT6E) (BSA
